首页>Transplant international :>mTOR INHIBITOR-BASED IMMUNOSUPPRESSION IS ASSOCIATED WITH A HIGHER FREQUENCY OF IFN gamma-PRODUCING EBV-SPECIFIC CD4(+) T CELLS AS COMPARED TO mTOR INHIBITOR-FREE THERAPY IN KIDNEY TRANSPLANT PATIENTS
mTOR INHIBITOR-BASED IMMUNOSUPPRESSION IS ASSOCIATED WITH A HIGHER FREQUENCY OF IFN gamma-PRODUCING EBV-SPECIFIC CD4(+) T CELLS AS COMPARED TO mTOR INHIBITOR-FREE THERAPY IN KIDNEY TRANSPLANT PATIENTS